TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmaprocess Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
180
|
134
|
72 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
83
|
51
|
17 |
| EBITDA |
85
|
54
|
20 |
| Total assets |
136
|
87
|
83 |
| Current assets |
131
|
78
|
71 |
| Current liabilities |
17
|
10
|
8 |
| Equity capital |
107
|
68
|
69 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
78.7%
|
78.2%
|
83.1% |
| Turnover per employee |
180
|
134
|
72 |
| Profit as a percentage of turnover |
46.1%
|
38.1%
|
23.6% |
| Return on assets (ROA) |
61.0%
|
58.6%
|
20.5% |
| Current ratio |
770.6%
|
780.0%
|
887.5% |
| Return on equity (ROE) |
77.6%
|
75.0%
|
24.6% |
| Change turnover |
46
|
67
|
-25 |
| Change turnover % |
34%
|
101%
|
-26% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.